Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response
- PMID: 28896007
- DOI: 10.1148/radiol.2017170252
Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response
Comment in
-
Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan.Radiology. 2017 Jul;284(1):301-303. doi: 10.1148/radiol.2017170252. Radiology. 2017. PMID: 28628405 No abstract available.
Comment on
-
Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan.Radiology. 2017 Jul;284(1):301-303. doi: 10.1148/radiol.2017170252. Radiology. 2017. PMID: 28628405 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
